
Magnolol
CAS No. 528-43-8
Magnolol( NSC 293099 )
Catalog No. M14871 CAS No. 528-43-8
Magnolol is isomeric to honokiol (sc-202653). Magnolol is an anxiolytic,anti-thrombotic and antibacterial.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
![]() ![]() |
25MG | 59 | In Stock |
![]() ![]() |
50MG | 87 | In Stock |
![]() ![]() |
100MG | 140 | In Stock |
![]() ![]() |
500MG | 350 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameMagnolol
-
NoteResearch use only, not for human use.
-
Brief DescriptionMagnolol is isomeric to honokiol (sc-202653). Magnolol is an anxiolytic,anti-thrombotic and antibacterial.
-
DescriptionMagnolol is isomeric to honokiol (sc-202653). Magnolol is an anxiolytic,anti-thrombotic and antibacterial. Inhibitor of nitric oxide (NO) and TNF-α production in LPS-activated macrophages by the suppression of inducible nitric oxide synthase.(In Vitro):Magnolol is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively. Magnolol (26.2-80 μM) binds to RXRαLBD and PPARγLBD in a dose dependent manner, with Kd values of 45.7 μM and 1.67 μM, respectively. Magnolol (1-20 μM) induces the transcription of PPRE in a dose-dependent manner, but shows no activity on RXRE transcription. Magnolol (1, 3, 10 μM) enhances adipocyte differentiation of both 3T3-L1 pre-adipocystes and C3H10T1/2 pluripotent stem cells in the presence of insulin. Magnolol (10 μM) upregulates mRNA expression of marker genes for adipocyte differentiation. Magnolol (1, 10 μM) shows an increase in basal and insulin-stimulated glucose uptake in differentiated 3T3-L1 adipocytes.(In Vivo):Magnolol (5-15 mg/kg, p.o.) significantly attenuates the phenotypic severity of dextran sulfate sodium (DSS)-induced colitis in mice. Magnolol (10, 15 mg/kg, p.o.) attenuates histopathological changes and myeloperoxidase activity in the colon of DSS-treated mice, decreases DSS-induced high levels of proinflammatory cytokines TNF-α, IL-1β and IL-6 in the colonic tissues. Magnolol (10 mg/kg, p.o.) also reverses abnormality of serum metabolome, and regulates tryptophan metabolic pathway in mice.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 293099
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB| p53| PPARγ
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number528-43-8
-
Formula Weight266.32
-
Molecular FormulaC18H18O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 53 mg/mL (199.0 mM); DMSO: 53 mg/mL (199.0 mM)
-
SMILESOC1=C(C=C(CC=C)C=C1)C1=C(O)C=CC(CC=C)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li M, et al. Y Sci. 2015 Oct;106(10):1341-50.
molnova catalog



related products
-
Sinomenine hydrochlo...
Extracted from Sinomenium Acutum Rehderett Wilson.
-
NF-κB/MAPK-IN-1
NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38.
-
Aurantiamide
Aurantiamide has anti-cancer anti-inflammatory and antinociceptive activities it may suppress the growth of malignant gliomas by blocking autophagic flux.Aurantiamide has an anti-neuroinflammatory effect on LPS stimulation through its inhibition of the NF-κB JNK and p38 pathways.